[Therapeutic modification of contractility under clinical conditions].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D002118:Calcium / Q000037:antagonists & inhibitors; D009202:Cardiomyopathies / Q000188:drug therapy*; D002395:Catecholamines / Q000627:therapeutic use; D004071:Digitalis Glycosides / Q000627:therapeutic use; D005934:Glucagon / Q000627:therapeutic use; D006801:Humans; D000451:Mineralocorticoid Receptor Antagonists; D009200:Myocardial Contraction / Q000187:drug effects*; D009573:Nitrites / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D002395:Catecholamines; D004071:Digitalis Glycosides; D000451:Mineralocorticoid Receptor Antagonists; D009573:Nitrites; D005934:Glucagon; D002118:Calcium
Therapeutische Beeinflussung der Kontraktilität in der Klinik